Article Information
History
- November 24, 2021.
Article Versions
- You are currently viewing Version 1 of this article (November 24, 2021 - 18:19).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Samuel Clifford, PhD1,2,
- Pauline Waight, BSc3,
- Jada Hackman, BSc1,2,
- Stephane Hué, PhD1,2,
- Charlotte M Gower, DPhil3,
- Freja CM Kirsebom, PhD3,
- Catriona Skarnes, MSc3,
- Louise Letley, MSc3,
- Jamie Lopez Bernal, PhD3,
- Nick Andrews, PhD3,
- Stefan Flasche, PhD1,2,+ and
- Elizabeth Miller, FRCPath2,3,+,#
- 1Centre for mathematical modelling of infectious diseases, London School of Hygiene & Tropical Medicine, LONDON WC1E 7HT
- 2Department for infectious disease epidemiology, London School of Hygiene & Tropical Medicine, LONDON WC1E 7HT
- 3National Infection Service, UK Health Security Agency, LONDON NW9 5EQ
- ↵#Corresponding author, Liz.Miller{at}lshtm.ac.uk, LSHTM, UK HSA
↵+ Contributed equally
Posted November 24, 2021.
Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England
